Together, these results indicate that highly expressed IKZF1–3 gain clinical significance for predicting the prognosis of patients with SKCM, IKZF3 is an independent prognostic factor of SKCM, thus suggesting that IKZF3 are prognostic biomarkers and immunotherapeutic targets of melanoma. Here, IKZF3 is linked to melanoma.